Arcus Biosciences (NYSE:RCUS) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Arcus Biosciences beat estimated earnings by 6.03%, reporting an EPS of $-1.09 versus an estimate of $-1.16.
Revenue was up $7.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14 which was followed by a 4.34% drop in the share price the next day.
Here’s a look at Arcus Biosciences’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.07 | -1.04 | -0.94 | -0.31 |
| EPS Actual | -0.93 | -0.90 | -0.93 | -0.96 |
| Revenue Estimate | 23.31M | 21.89M | 21.12M | 79.42M |
| Revenue Actual | 34.00M | 33.58M | 26.76M | 18.00M |
To track all earnings releases for Arcus Biosciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
